Piramal Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,751.77 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.60 per cent from ₹2,139.87 crore. This corresponds to a year-on-year *(YoY) decline of 0.08 per cent.
Operating Profit
Operating Profit stands at ₹284.74 crore, reflecting a quarter-on-quarter *(QoQ) increase of 84.15 per cent from ₹154.62 crore. This corresponds to a year-on-year *(YoY) decline of 49.24 per cent.
PBDT
PBDT stands at ₹261.38 crore, reflecting a quarter-on-quarter *(QoQ) increase of 119.87 per cent from ₹118.88 crore. This corresponds to a year-on-year *(YoY) decline of 49.30 per cent.
Profit Before Tax
Profit Before Tax stands at ₹43.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 145.81 per cent from ₹-93.86 crore. This corresponds to a year-on-year *(YoY) decline of 84.24 per cent.
Net Profit
Net Profit stands at ₹-8.83 crore, reflecting a quarter-on-quarter *(QoQ) increase of 93.52 per cent from ₹-136.19 crore. This represents a 105.75 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Piramal Pharma Ltd News
Piramal Pharma Ltd Earnings
- YOY
- QOQ
Piramal Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Piramal Pharma Ltd Research Reports
Piramal Pharma Ltd Financial Reports
Piramal Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Piramal Pharma | 0.17% | 1.23% | 8.70% | 7.35% | 18.63% | -11.35% |
| Acutaas Chemical | -5.75% | -10.92% | -8.21% | 30.60% | 88.39% | 182.32% |
| Sai Life | -0.48% | -4.98% | -1.27% | 15.42% | 50.23% | 49.32% |
| Rubicon Research | -1.59% | 0.38% | 7.12% | 58.57% | 132.07% | 142.11% |
| Neuland Labs. | 0.44% | -1.96% | 2.81% | 25.86% | 45.10% | 33.86% |
| Pfizer | -1.01% | 0.96% | 4.92% | -3.63% | 0.25% | -12.68% |
| Granules India | -2.61% | -4.83% | 3.99% | 19.93% | 44.03% | 80.07% |
Company Info
Company Information
Chairperson / Executive Director : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Executive Director & CFO : Vivek Valsaraj
Independent Non Exe. Director : Nathalie Leitch
Non-Exec & Non-Independent Dir : Amit Jain
Independent Non Exe. Director : Jairaj Manohar Purandare
Independent Non Exe. Director : Sridhar Gorthi
Independent Non Exe. Director : Peter Stevenson
Independent Non Exe. Director : Vibha Paul Rishi
Independent Non Exe. Director : AMIT SONI
Company Sec. & Compli. Officer : Maneesh Sharma